Perlmutter Cancer Center

If you have been diagnosed with Stage 0 or I breast cancer, also known as ductal carcinoma in situ (DCIS) or T1 breast cancer, you may qualify to participate in a clinical trial evaluating how well people tolerate two different doses of radiotherapy delivered within 1 week. Patients will be assigned randomly (like the flip of a coin) to one dose of radiotherapy or the other. The main goal of this study is to compare two different doses of radiation treatment in post-menopausal women with breast cancer and measure long-term effects of radiation fibrosis (thickening or firming of the breast that can be a side effect of radiotherapy) and other skin changes post-radiation treatment.